LEP and type 2 diabetes mellitus: The stratification of patients with ACS based on leptin levels, particularly those with T2DM, may guide clinical decision making and optimize the management of these patients, potentially leading to more intensive monitoring, aggressive risk factor modification, and targeted therapies.